Topics Engaged In
-
- Topic
- Voices
- Last Post
-
-
New BRAF/MEK inhibitors coming to market
Started by:
in: Dosing and administration
- 7
- October 8, 2018 at 10:07 am
-
Adjuvant Nivolumab at 480 side effect
Started by:
in: Side-effect management
- 5
- September 30, 2018 at 6:29 pm
-
Nivolumab dosing and Medicare
Started by:
in: Reimbursement
- 7
- July 23, 2018 at 4:02 pm
-
Herbal medications
Started by:
in: Alternative/complementary therapies
- 5
- June 22, 2018 at 7:29 pm
-
Pembro plus Epacadostat
Started by:
in: Other
- 6
- June 11, 2018 at 2:29 pm
-
BRAF testing for adjuvant therapy
Started by:
in: Other
- 6
- June 3, 2018 at 6:18 am
-
Adjuvant Immunotherapy in stage IIIA patients
Started by:
in: Expectations for therapy
- 7
- May 5, 2018 at 8:59 pm
-
Premedication
Started by:
in: Dosing and administration
- 5
- April 29, 2018 at 2:54 pm
-
Skin sensitivity
Started by:
in: Side-effect management
- 5
- April 26, 2018 at 12:04 am
-
PET/CT scans
Started by:
in: Other
- 7
- April 13, 2018 at 5:00 pm
-
Hypercalcemia
Started by:
in: Side-effect management
- 4
- April 8, 2018 at 3:42 pm
-
Gastritis with IO
Started by:
in: Side-effect management
- 2
- April 7, 2018 at 10:45 pm
-
Survivorship plans
Started by:
in: Coordination of care
- 7
- March 29, 2018 at 9:39 pm
-
Family planning
Started by:
in: Fertility
- 5
- March 29, 2018 at 9:31 pm
-
Opdivo dosing changes
Started by:
in: Dosing and administration
- 5
- March 29, 2018 at 9:25 pm
-
New BRAF/MEK inhibitors coming to market